SCHEMBL23360236

SCHEMBL23360236

CC(C)(C)OC(=O)N1CCC(Oc2ccnc3cc(Cl)ccc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPK1 P28482 2/20 0.56
GLA P06280 1/20 0.56
MAPT P10636 1/20 0.56
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
HSD17B10 Q99714 1/20 0.54
IDE P14735 3/20 0.50
IDO1 P14902 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PDE4A P27815 2/20 0.48
PDE4B Q07343 2/20 0.48
PDE4C Q08493 2/20 0.48
PDE4D Q08499 2/20 0.48
CACNB4 O00305 2/20 0.48
CACNA1A O00555 2/20 0.48
CACNA1G O43497 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862560 1.00 ALDH1A1 (0.56) ALDH1A1LMNASMN1; SMN2MAPK1GLA
SCHEMBL23360413 0.89 PDE4D (0.52) IDO1KMT2APDE4APDE4BPDE4C
SCHEMBL29862539 0.89 PDE4D (0.52) IDO1KMT2APDE4APDE4BPDE4C
SCHEMBL23360518 0.88 IDO1 (0.60) SMN1; SMN2IDO1PDE4APDE4BPDE4C
SCHEMBL29862743 0.88 IDO1 (0.60) SMN1; SMN2IDO1PDE4APDE4BPDE4C
SCHEMBL24010678 0.87 MET (0.54) ALDH1A1IDO1MEN1KMT2APDE4A
SCHEMBL23707520 0.85 IDO1 (0.52) IDO1PDE4APDE4BPDE4CPDE4D
SCHEMBL1873094 0.83 ALDH1A1 (0.61) ALDH1A1LMNASMN1; SMN2MAPK1GLA
SCHEMBL23360277 0.82 IDO1 (0.56) IDO1PDE4APDE4BPDE4CPDE4D
SCHEMBL29862644 0.82 IDO1 (0.56) IDO1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL ALDH1A1 439/4885LMNA 1955/4885SMN1; SMN2 387/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL ALDH1A1 439/4885LMNA 1955/4885SMN1; SMN2 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.